Bisphosphonate mucosal injury—the end of the story?
Author:
- F LanzaFLF Lanza
- 1 February 2003
- journal article
- editorial
- Published by Elsevier in Digestive and Liver Disease
- Vol. 35 (2) , 67-70
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- N‐bisphosphonates cause gastric epithelial injury independent of effects on the microcirculationAlimentary Pharmacology & Therapeutics, 1999
- Alendronate gastric ulcersAlimentary Pharmacology & Therapeutics, 1999
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Alendronate-associated esophagitis: endoscopic and pathologic featuresGastrointestinal Endoscopy, 1998
- Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of AgeNew England Journal of Medicine, 1998
- AlendronateDrugs, 1997
- “Pill Esophagitis” — The Case of AlendronateNew England Journal of Medicine, 1996
- Gastric Adaptation to Nonsteroidal Anti-Inflammatory Drugs in ManScandinavian Journal of Gastroenterology, 1992
- Gastric adaptation occurs with aspirin administration in manDigestive Diseases and Sciences, 1983